Pictet Asset Management (Switzerland)’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$642K Buy
24,570
+3,127
+15% +$82.6K ﹤0.01% 1131
2023
Q1
$592K Hold
21,443
﹤0.01% 1171
2022
Q4
$487K Buy
+21,443
New +$597K ﹤0.01% 1262

Other funds holding PRVA

Pictet Asset Management (Switzerland)'s PRVA Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Privia Health (PRVA) stake by 15% in Q2 2023, buying an estimated $82.6K and bringing the position to 24,570 shares worth $642K. The position accounts for ﹤0.01% of the portfolio, ranked #1131.

Pictet Asset Management (Switzerland) first reported a position in PRVA in Q4 2022 and has held it in 3 quarters since. 234 funds tracked by Wall St. Rank hold PRVA as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 24,570 shares of Privia Health worth $642K as of Q2 2023.
  • Pictet Asset Management (Switzerland) bought 3,127 Privia Health shares in Q2 2023, an estimated $82.6K.
  • Privia Health made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1131 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Privia Health in Q4 2022 and has held it in 3 quarters since.
  • 234 funds tracked by Wall St. Rank held Privia Health as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.